IBEX Limited (IBEX) is a Information Technology Services company in the Technology sector, currently trading at $28.46. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of IBEX = $220.79 (+675.8% from the current price, the stock appears undervalued). Analyst consensus target is IBEX = $24 (-15.7% upside).
Valuation: IBEX trades at a trailing Price-to-Earnings (P/E) of 8.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.17.
Financials: revenue is $558M, +4.3%/yr average growth. Net income is $37M, growing at +21.1%/yr. Net profit margin is 6.6% (thin). Gross margin is 30.9% (+6.7 pp trend).
Balance sheet: total debt is $70M against $134M equity (Debt-to-Equity (D/E) ratio 0.52, moderate). Current ratio is 1.82 (strong liquidity). Debt-to-assets is 25.5%. Total assets: $273M.
Analyst outlook: 2 / 6 analysts rate IBEX as buy (33%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 70/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 83/100 (Pass), Moat 44/100 (Fail), Future 16/100 (Fail), Income 45/100 (Partial).
